Abstract
Aged skin is an easily accessible and cost-effective model for the determination of aging of the whole human organism and eventually for the prediction of other age-related comorbidities. Its endogenous variable is called intrinsic aging, while the effect of external factors, such as UV radiation, is termed extrinsic aging. In this overview, key hallmarks, which determine intrinsic aging and extrinsic aging, are mentioned. These include aging of the cellular components of the skin, as well as of the dermal components, i.e., the extracellular matrix. Furthermore, the most common age-related diseases are presented. At last, evidence for the predicting value of aged skin for the development or course of certain pathological conditions is elucidated.
References
Vina J, et al. Theories of ageing. IUBMB Life. 2007;59:249–54.
Nikolakis G, et al. Skin mirrors human aging. Horm Mol Biol Clin Investig. 2013;16:13–28.
Ganceviciene R, et al. Skin anti-aging strategies. Dermatoendocrinol. 2012;4:308–19.
Makrantonaki E, et al. Genetics and skin aging. Dermatoendocrinol. 2012;4:280–4.
Kinn PM, et al. Age-dependent variation in cytokines, chemokines, and biologic analytes rinsed from the surface of healthy human skin. Sci Rep. 2015;5:10472.
Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol. 2011;29:3–14.
Cevenini E, et al. Human models of aging and longevity. Expert Opin Biol Ther. 2008;8:1393–405.
Callaghan TM, Wilhelm KP. A review of ageing and an examination of clinical methods in the assessment of ageing skin. Part 2: clinical perspectives and clinical methods in the evaluation of ageing skin. Int J Cosmet Sci. 2008;30:323–32.
El-Domyati M, et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol. 2002;11:398–405.
Kligman LH. Photoaging. Manifestations, prevention, and treatment. Clin Geriatr Med. 1989;5:235–51.
Lock-Andersen J, et al. Epidermal thickness, skin pigmentation and constitutive photosensitivity. Photodermatol Photoimmunol Photomed. 1997;13:153–8.
Makrantonaki E, Zouboulis CC. Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci. 2007;1119:40–50.
Moragas A, et al. Mathematical morphologic analysis of aging-related epidermal changes. Anal Quant Cytol Histol. 1993;15:75–82.
Rawlings AV. Ethnic skin types: are there differences in skin structure and function? Int J Cosmet Sci. 2006;28:79–93.
Chu M, Kollias N. Documentation of normal stratum corneum scaling in an average population: features of differences among age, ethnicity and body site. Br J Dermatol. 2011;164:497–507.
Diridollou S, et al. Comparative study of the hydration of the stratum corneum between four ethnic groups: influence of age. Int J Dermatol. 2007;46 Suppl 1:11–4.
Tsukahara K, et al. Comparison of age-related changes in wrinkling and sagging of the skin in Caucasian females and in Japanese females. J Cosmet Sci. 2004;55:351–71.
Nouveau-Richard S, et al. Skin ageing: a comparison between Chinese and European populations. A pilot study. J Dermatol Sci. 2005;40:187–93.
Valet F, et al. Assessing the reliability of four severity scales depicting skin ageing features. Br J Dermatol. 2009;161:153–8.
Allsopp RC, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89:10114–8.
Dimri GP, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92:9363–7.
Harman D. The free radical theory of aging. Antioxid Redox Signal. 2003;5:557–61.
Makrantonaki E, et al. Skin and brain age together: the role of hormones in the ageing process. Exp Gerontol. 2010;45:801–13.
Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc. 1990;65:375–98.
Michikawa Y, et al. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 1999;286:774–9.
Mancini M, et al. MicroRNAs in human skin ageing. Ageing Res Rev. 2014;17:9–15.
Janson D, et al. Effects of serially passaged fibroblasts on dermal and epidermal morphogenesis in human skin equivalents. Biogerontology. 2013;14:131–40.
Gilhar A, et al. Ageing of human epidermis: the role of apoptosis, Fas and telomerase. Br J Dermatol. 2004;150:56–63.
Waldera Lupa DM, et al. Characterization of skin aging-associated secreted proteins (SAASP) produced by dermal fibroblasts isolated from intrinsically aged human skin. J Invest Dermatol. 2015;135:1954–68.
Janson D, et al. Papillary fibroblasts differentiate into reticular fibroblasts after prolonged in vitro culture. Exp Dermatol. 2013;22:48–53.
Dos Santos M, et al. In vitro 3-D model based on extending time of culture for studying chronological epidermis aging. Matrix Biol. 2015;47:85–97.
Franceschi C, et al. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine. 2000;18:1717–20.
Giacomoni PU, et al. Aging of human skin: review of a mechanistic model and first experimental data. IUBMB Life. 2000;49:259–63.
Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5:133–9.
Plackett TP, et al. Aging and innate immune cells. J Leukoc Biol. 2004;76:291–9.
Plowden J, et al. Innate immunity in aging: impact on macrophage function. Aging Cell. 2004;3:161–7.
Ye J, et al. Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family. Exp Dermatol. 2002;11:209–16.
Coppe JP, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853–68.
Freund A, et al. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16:238–46.
Elias PM, Ghadially R. The aged epidermal permeability barrier: basis for functional abnormalities. Clin Geriatr Med. 2002;18:103–20. Vii.
Tsutsumi M, Denda M. Paradoxical effects of beta-estradiol on epidermal permeability barrier homeostasis. Br J Dermatol. 2007;157:776–9.
Briganti S, et al. Modulation of PPARgamma provides new insights in a stress induced premature senescence model. PLoS One. 2014;9:e104045.
Robinson MK, et al. Genomic-driven insights into changes in aging skin. J Drugs Dermatol. 2009;8:s8–11.
Nikolakis G, et al. Ex vivo human skin and SZ95 sebocytes exhibit a homoeostatic interaction in a novel coculture contact model. Exp Dermatol. 2015;24:497–502.
Engelke M, et al. Effects of xerosis and ageing on epidermal proliferation and differentiation. Br J Dermatol. 1997;137:219–25.
Pochi PE, et al. Age-related changes in sebaceous gland activity. J Invest Dermatol. 1979;73:108–11.
Zouboulis CC, Boschnakow A. Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol. 2001;26:600–7.
Makrantonaki E, et al. Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell. 2006;5:331–44.
Makrantonaki E, et al. Identification of biomarkers of human skin ageing in both genders. Wnt signalling – a label of skin ageing? PLoS One. 2012;7:e50393.
Chi W, et al. Dermal papilla cell number specifies hair size, shape and cycling and its reduction causes follicular decline. Development. 2013;140:1676–83.
Yang YC, et al. Androgen receptor accelerates premature senescence of human dermal papilla cells in association with DNA damage. PLoS One. 2013;8:e79434.
Arck PC, et al. Towards a “free radical theory of graying”: melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage. FASEB J. 2006;20:1567–9.
Peters EM, et al. Graying of the human hair follicle. J Cosmet Sci. 2011;62:121–5.
Seiberg M. Age-induced hair greying – the multiple effects of oxidative stress. Int J Cosmet Sci. 2013;35:532–8.
Schuler N, Rube CE. Accumulation of DNA damage-induced chromatin alterations in tissue-specific stem cells: the driving force of aging? PLoS One. 2013;8:e63932.
Inoue M, Katakami C. The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest Ophthalmol Vis Sci. 1993;34:2313–5.
Toole BP. Hyaluronan in morphogenesis. J Intern Med. 1997;242:35–40.
Baumann L. Skin ageing and its treatment. J Pathol. 2007;211:241–51.
Papakonstantinou E, et al. Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol. 2012;4:253–8.
Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 1998;10:602–8.
Isnard N, et al. Regulation of elastase-type endopeptidase activity, MMP-2 and MMP-9 expression and activation in human dermal fibroblasts by fucose and a fucose-rich polysaccharide. Biomed Pharmacother. 2002;56:258–64.
Longas MO, et al. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr Res. 1987;159:127–36.
Meyer LJ, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol. 1994;102:385–9.
Rock K, et al. miR-23a-3p causes cellular senescence by targeting hyaluronan synthase 2: possible implication for skin aging. J Invest Dermatol. 2015;135:369–77.
Isnard N, et al. Effect of sulfated GAGs on the expression and activation of MMP-2 and MMP-9 in corneal and dermal explant cultures. Cell Biol Int. 2003;27:779–84.
Langton AK, et al. A new wrinkle on old skin: the role of elastic fibres in skin ageing. Int J Cosmet Sci. 2010;32:330–9.
Naylor EC, et al. Molecular aspects of skin ageing. Maturitas. 2011;69:249–56.
Park HY, et al. A long-standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Exp Dermatol. 2011;20:969–74.
Paul RG, Bailey AJ. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol. 1996;28:1297–310.
Bierhaus A, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83:876–86.
Fleming TH, et al. Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review. Gerontology. 2011;57:435–43.
Gkogkolou P, Bohm M. Advanced glycation end products: key players in skin aging? Dermatoendocrinol. 2012;4:259–70.
Cerami C, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A. 1997;94:13915–20.
Glenn JV, et al. Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch’s membrane leading to accurate, nondestructive prediction of ocular aging. FASEB J. 2007;21:3542–52.
Sell DR, et al. Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane. Diabetologia. 1993;36:936–41.
Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001;85:746–53.
Vlassara H, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A. 2002;99:15596–601.
Thijssen DH et al. Arterial structure and function in vascular ageing: “Are you as old as your arteries?”. J Physiol. 2015.
Wang Y, et al. Effect of glucose on the biomechanical function of arterial elastin. J Mech Behav Biomed Mater. 2015;49:244–54.
Fang M, et al. Advanced glycation end-products accelerate the cardiac aging process through the receptor for advanced glycation end-products/transforming growth factor-beta-Smad signaling pathway in cardiac fibroblasts. Geriatr Gerontol Int. 2015;28:12499.
Wu X, Monnier VM. Enzymatic deglycation of proteins. Arch Biochem Biophys. 2003;419:16–24.
Xue M, et al. Glyoxalase in ageing. Semin Cell Dev Biol. 2011;22:293–301.
Dyer DG, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest. 1993;91:2463–9.
Jeanmaire C, et al. Glycation during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study. Br J Dermatol. 2001;145:10–8.
Avery NC, Bailey AJ. The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol Biol (Paris). 2006;54:387–95.
Degroot J, et al. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum. 2001;44:2562–71.
Mizutari K, et al. Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. J Invest Dermatol. 1997;108:797–802.
Alikhani Z, et al. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem. 2005;280:12087–95.
Zhu P, et al. Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA. Arch Dermatol Res. 2011;303:339–50.
Berge U, et al. Sugar-induced premature aging and altered differentiation in human epidermal keratinocytes. Ann N Y Acad Sci. 2007;1100:524–9.
Ravelojaona V, et al. Expression of senescence-associated beta-galactosidase (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and fucose or rhamnose-rich polysaccharides. Arch Gerontol Geriatr. 2009;48:151–4.
Sejersen H, Rattan SI. Dicarbonyl-induced accelerated aging in vitro in human skin fibroblasts. Biogerontology. 2009;10:203–11.
Hofmann B, et al. Advanced glycation end product associated skin autofluorescence: a mirror of vascular function? Exp Gerontol. 2013;48:38–44.
Yamagishi S, et al. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: a novel marker of vascular complications in high-risk patients for cardiovascular disease. Int J Cardiol. 2015;185:263–8.
Pennacchi PC, et al. Glycated reconstructed human skin as a platform to study pathogenesis of skin aging. Tissue Eng Part A. 2015;1:1.
Poundarik AA, et al. A direct role of collagen glycation in bone fracture. J Mech Behav Biomed Mater. 2015;50:82–92.
Sestier B. [Hematopoietic stem cell exhaustion and advanced glycation end-products in the unexplained anemia of the elderly]. Rev Esp Geriatr Gerontol. 2015;50:223–31.
Kandarakis SA, et al. Dietary glycotoxins induce RAGE and VEGF up-regulation in the retina of normal rats. Exp Eye Res. 2015;137:1–10.
Zolla V, et al. Aging-related anatomical and biochemical changes in lymphatic collectors impair lymph transport, fluid homeostasis, and pathogen clearance. Aging Cell. 2015;14:582–94.
Fuchs E, Chen T. A matter of life and death: self-renewal in stem cells. EMBO Rep. 2013;14:39–48.
Thomson JA, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.
Zouboulis CC, et al. Human skin stem cells and the ageing process. Exp Gerontol. 2008;43:986–97.
Potten CS. The epidermal proliferative unit: the possible role of the central basal cell. Cell Tissue Kinet. 1974;7:77–88.
Biernaskie JA, et al. Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny. Nat Protoc. 2006;1:2803–12.
Chen FG, et al. Clonal analysis of nestin(−) vimentin(+) multipotent fibroblasts isolated from human dermis. J Cell Sci. 2007;120:2875–83.
Kim J-H, et al. Adipose-derived stem cells as a new therapeutic modality for ageing skin. Exp Dermatol. 2011;20:383–7.
Yang YI, et al. Ex vivo organ culture of adipose tissue for in situ mobilization of adipose-derived stem cells and defining the stem cell niche. J Cell Physiol. 2010;224:807–16.
Grove GL, Kligman AM. Age-associated changes in human epidermal cell renewal. J Gerontol. 1983;38:137–42.
Racila D, Bickenbach JR. Are epidermal stem cells unique with respect to aging? Aging (Albany NY). 2009;1:746–50.
Conboy IM, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433:760–4.
Sharpless NE, Depinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol. 2007;8:703–13.
Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci U S A. 1987;84:2302–6.
Ressler S, et al. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell. 2006;5:379–89.
Giangreco A, et al. Human skin aging is associated with reduced expression of the stem cell markers beta1 integrin and MCSP. J Invest Dermatol. 2010;130:604–8.
Ruzankina Y, et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell. 2007;1:113–26.
Giangreco A, et al. Epidermal stem cells are retained in vivo throughout skin aging. Aging Cell. 2008;7:250–9.
Stern MM, Bickenbach JR. Epidermal stem cells are resistant to cellular aging. Aging Cell. 2007;6:439–52.
Asumda FZ. Age-associated changes in the ecological niche: implications for mesenchymal stem cell aging. Stem Cell Res Ther. 2013;4:47.
Doles J, et al. Age-associated inflammation inhibits epidermal stem cell function. Genes Dev. 2012;26:2144–53.
Bromberg JF, et al. Stat3 as an oncogene. Cell. 1999;98:295–303.
Demaria M, et al. STAT3 can serve as a hit in the process of malignant transformation of primary cells. Cell Death Differ. 2012;19:1390–7.
Demaria M, Poli V. Pro-malignant properties of STAT3 during chronic inflammation. Oncotarget. 2012;3:359–60.
Castilho RM, et al. mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell. 2009;5:279–89.
Biernaskie J, et al. SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell. 2009;5:610–23.
Liu S, et al. The PI3K-Akt pathway inhibits senescence and promotes self-renewal of human skin-derived precursors in vitro. Aging Cell. 2011;10:661–74.
Beaudry VG, Attardi LD. SKP-ing TAp63: stem cell depletion, senescence, and premature aging. Cell Stem Cell. 2009;5:1–2.
Paris M, et al. Regulation of skin aging and heart development by TAp63. Cell Death Differ. 2012;19:186–93.
Su X, Flores ER. TAp63: the fountain of youth. Aging (Albany NY). 2009;1:866–9.
Bufalino MR, et al. The asymmetric segregation of damaged proteins is stem cell-type dependent. J Cell Biol. 2013;201:523–30.
Florian MC, Geiger H. Concise review: polarity in stem cells, disease, and aging. Stem Cells. 2010;28:1623–9.
Chung JH, et al. Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol. 2000;115:177–82.
Bernstein EF, et al. Enhanced elastin and fibrillin gene expression in chronically photodamaged skin. J Invest Dermatol. 1994;103:182–6.
Mitchell RE. Chronic solar dermatosis: a light and electron microscopic study of the dermis. J Invest Dermatol. 1967;48:203–20.
Berneburg M, et al. Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system. Photochem Photobiol. 1997;66:271–5.
Sugimoto M, et al. Telomere length of the skin in association with chronological aging and photoaging. J Dermatol Sci. 2006;43:43–7.
Gilchrest BA. A review of skin ageing and its medical therapy. Br J Dermatol. 1996;135:867–75.
Ernster VL, et al. Facial wrinkling in men and women, by smoking status. Am J Public Health. 1995;85:78–82.
Kadunce DP, et al. Cigarette smoking: risk factor for premature facial wrinkling. Ann Intern Med. 1991;114:840–4.
Yin L, et al. Skin aging induced by ultraviolet exposure and tobacco smoking: evidence from epidemiological and molecular studies. Photodermatol Photoimmunol Photomed. 2001;17:178–83.
Just M, et al. Effect of smoking on skin elastic fibres: morphometric and immunohistochemical analysis. Br J Dermatol. 2007;156:85–91.
Model D. Smoker’s face: an underrated clinical sign? Br Med J (Clin Res Ed). 1985;291:1760–2.
Tzellos TG, et al. Differential hyaluronan homeostasis and expression of proteoglycans in juvenile and adult human skin. J Dermatol Sci. 2011;61:69–72.
Makrantonaki E, et al. Skin diseases in geriatric patients. Epidemiologic data. Hautarzt. 2012;63:938–46.
Eklof B, et al. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg. 2009;49:498–501.
Nicolaides AN, et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol. 2008;27:1–59.
Rabe E, et al. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31:105–15.
Dissemond J. Medications. A rare cause for leg ulcers. Hautarzt. 2011;62:516–23.
Theisen S, et al. Pressure ulcers in older hospitalised patients and its impact on length of stay: a retrospective observational study. J Clin Nurs. 2012;21:380–7.
Laube S, Farrell AM. Bacterial skin infections in the elderly: diagnosis and treatment. Drugs Aging. 2002;19:331–42.
Na CR, et al. Elderly adults and skin disorders: common problems for nondermatologists. South Med J. 2012;105:600–6.
Gilchrest BA, et al. Effect of chronologic aging and ultraviolet irradiation on Langerhans cells in human epidermis. J Invest Dermatol. 1982;79:85–8.
Sunderkotter C, et al. Aging and the skin immune system. Arch Dermatol. 1997;133:1256–62.
Schmidt E, Zillikens D. Diagnosis and clinical severity markers of bullous pemphigoid. F1000 Med Rep 1. 2009.
Ingen-Housz-Oro S, et al. Pemphigus in elderly adults: clinical presentation, treatment, and prognosis. J Am Geriatr Soc. 2012;60:1185–7.
Langan SM, et al. Bullous pemphigoid and pemphigus vulgaris–incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.
Ejaz A, et al. Presentation of early onset psoriasis in comparison with late onset psoriasis: a clinical study from Pakistan. Indian J Dermatol Venereol Leprol. 2009;75:36–40.
Ferrandiz C, et al. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002;46:867–73.
Kwon HH, et al. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype? Int J Dermatol. 2012;51:53–8.
Bellei B, et al. Vitiligo: a possible model of degenerative diseases. PLoS One. 2013;8:e59782.
Gallagher RP. Sunscreens in melanoma and skin cancer prevention. CMAJ. 2005;173:244–5.
Goldberg LH, Mamelak AJ. Review of actinic keratosis. Part I: etiology, epidemiology and clinical presentation. J Drugs Dermatol. 2010;9:1125–32.
Schmitt JV, Miot HA. Actinic keratosis: a clinical and epidemiological revision. An Bras Dermatol. 2012;87:425–34.
Traianou A, et al. Risk factors for actinic keratosis in eight European centres: a case–control study. Br J Dermatol. 2012;167 Suppl 2:36–42.
Baxter JM, et al. Facial basal cell carcinoma. BMJ. 2012;345:e5342.
Bath-Hextall F, et al. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer. 2007;121:2105–8.
Perrotta RE, et al. Non-melanoma skin cancers in elderly patients. Crit Rev Oncol Hematol. 2011;80:474–80.
Samarasinghe V, Madan V. Nonmelanoma skin cancer. J Cutan Aesthet Surg. 2012;5:3–10.
Chamberlain AJ, et al. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138:609–14.
Chang AE, et al. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664–78.
Lasithiotakis KG, et al. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer. 2006;107:1331–9.
Macdonald JB, et al. Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer. 2011;2:538–43.
Swetter SM, et al. Melanoma in the older person. Oncology (Williston Park). 2004;18:1187–96; discussion 1196–1187.
Tsai S, et al. Epidemiology and treatment of melanoma in elderly patients. Nat Rev Clin Oncol. 2010;7:148–52.
Makrantonaki E, et al. Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol. 2008;43:939–46.
Laron Z. Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? Mech Ageing Dev. 2005;126:305–7.
Tomlinson JW, et al. Association between premature mortality and hypopituitarism. The Lancet. 2001;357:425–31.
Zouboulis CC, et al. Sexual hormones in human skin. Horm Metab Res. 2007;39:85–95.
Herzog V, et al. Biological roles of APP in the epidermis. Eur J Cell Biol. 2004;83:613–24.
Kvetnoi IM, et al. Expression of beta-amyloid and tau-protein in mastocytes in Alzheimer disease. Arkh Patol. 2003;65:36–9.
Yaar M, Gilchrest BA. Human melanocytes as a model system for studies of Alzheimer disease. Arch Dermatol. 1997;133:1287–91.
Hossini AM, et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer’s disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics. 2015;16:015–1262.
Mukherjee A, Swarnakar S. Implication of matrix metalloproteinases in regulating neuronal disorder. Mol Biol Rep. 2015;42:1–11.
Debusk FL. The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. J Pediatr. 1972;80:697–724.
Merideth MA, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med. 2008;358:592–604.
Scaffidi P, Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol. 2008;10:452–9.
Wenzel V, et al. Naive adult stem cells from patients with Hutchinson-Gilford progeria syndrome express low levels of progerin in vivo. Biol Open. 2012;1:516–26.
Mcclintock D, et al. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One. 2007;2:e1269.
Rosengardten Y, et al. Stem cell depletion in Hutchinson-Gilford progeria syndrome. Aging Cell. 2011;10:1011–20.
Capell BC, et al. From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging. J Invest Dermatol. 2009;129:2340–50.
Davis T, et al. The role of cellular senescence in Werner syndrome: toward therapeutic intervention in human premature aging. Ann N Y Acad Sci. 2007;1100:455–69.
Winkelspecht K, et al. Metageria–clinical manifestations of a premature aging syndrome. Hautarzt. 1997;48:657–61.
Sakai S, et al. Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis. Br J Dermatol. 2005;153:319–23.
Braverman IM. Elastic fiber and microvascular abnormalities in aging skin. Clin Geriatr Med. 1989;5:69–90.
Petrofsky J, et al. The influence of aging and diabetes on heat transfer characteristics of the skin to a rapidly applied heat source. Diabetes Technol Ther. 2010;12:1003–10.
Petrofsky JS, et al. Skin heat dissipation: the influence of diabetes, skin thickness, and subcutaneous fat thickness. Diabetes Technol Ther. 2008;10:487–93.
Monami M, et al. Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res Clin Pract. 2008;79:56–60.
Lutgers HL, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care. 2006;29:2654–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Nikolakis, G., Makrantonaki, E., Zouboulis, C. (2015). Aging Skin as a Diagnostic Tool for Internal Diseases: A Chance for Dermatology. In: Farage, M., Miller, K., Maibach, H. (eds) Textbook of Aging Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27814-3_125-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-27814-3_125-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27814-3
eBook Packages: Springer Reference MedicineReference Module Medicine